European Case Law Identifier: | ECLI:EP:BA:1993:T045691.19931103 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 03 November 1993 | ||||||||
Case number: | T 0456/91 | ||||||||
Application number: | 81305426.9 | ||||||||
IPC class: | A61K 9/50 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Microencapsulation of water-soluble polypeptides | ||||||||
Applicant name: | Syntex (USA) Inc. | ||||||||
Opponent name: | 01) Debiopharm S.A. 02) Ipsen Biotech société au nom collectif 03) The Administrators of the Tulane Educational Fund 05) Deghenghi, Roman 08) Ferring Arzneimittel GmbH 09) Ares-Sereno N.V. 10) Stolle Research & Development Corporation |
||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Amendments - extension of original disclosure (no) Extension of protection (no) Clarity (yes) - claims supported by description - broad claim not unclear Sufficiency of disclosure (yes) - no undue burden to skilled person Priority right (yes) - no previous disclosure of claimed invention Novelty (yes) - claimed invention not part of the state of the art Inventive step (yes) - claimed solution not foreshadowed by state of the art |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t910456eu1.html
Date retrieved: 17 May 2021
10 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II A 6.3.5 Use in the examination relating to the clarity requirement pursuant to Article 84 EPC